Deparment of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas- School of Public Health, Houston, TX, USA.
Division of Urology, UTHealth McGovern Medical School, Houston, TX, USA.
Clin Endocrinol (Oxf). 2018 Jan;88(1):58-65. doi: 10.1111/cen.13501. Epub 2017 Nov 20.
Testosterone deficiency (TD, total testosterone ≤350 ng/dL [12.15 nmol L ]) and obesity epidemic are growing in parallel in the United States. Yet, the sequelae of TD and obesity on the risk of mortality remain unclear.
To investigate whether the co-occurrence of TD and overall obesity (body mass index ≥30 kg/m ), and abdominal obesity (waist circumference ≥102 cm), is associated with a risk of all-cause mortality in American men.
The data were obtained from the NHANES 1999-2004 and the Linked Mortality File (December 31, 2011). A total of 948 participants aged ≥20 years old with endogenous sex hormones and adiposity measurements data were included in this study.
Over a median of 9.5 years of follow-up, 142 men died of any cause in this cohort. Multivariable analysis showed a 2.60 fold increased risk of death among men with TD compared with men without TD (Hazard Ratio [HR] = 2.60; 95% confidence interval [CI] = 1.20-5.80). No evidence for interaction between TD and overall or abdominal obesity with risk of death (P ≥ .80). However, only after comparing men with TD and abdominal obesity with men without TD and no abdominal obesity, we found a 3.30 fold increased risk of death (HR = 3.30, 95% CI = 1.21-8.71).
Men with co-occurrence of TD and abdominal obesity have a higher risk of mortality. The effect of co-occurrence of TD and abdominal obesity should be further explored with a larger and longer follow-up time study.
在美国,睾丸功能减退症(TD,总睾酮≤350ng/dL[12.15nmol/L])和肥胖症呈平行增长趋势。然而,TD 和肥胖症对死亡率的影响仍不清楚。
研究美国男性中睾丸功能减退症和整体肥胖症(体重指数≥30kg/m²)以及腹型肥胖症(腰围≥102cm)共存与全因死亡率风险之间的关系。
数据来自 NHANES 1999-2004 年和关联死亡率档案(2011 年 12 月 31 日)。本研究共纳入了 948 名年龄≥20 岁且具有内源性性激素和肥胖测量数据的参与者。
在中位随访 9.5 年期间,该队列中有 142 名男性死于任何原因。多变量分析显示,与无睾丸功能减退症的男性相比,有睾丸功能减退症的男性死亡风险增加了 2.60 倍(危险比[HR] = 2.60;95%置信区间[CI] = 1.20-5.80)。TD 与整体或腹型肥胖症与死亡风险之间没有交互作用的证据(P≥.80)。然而,仅在比较有睾丸功能减退症和腹型肥胖症的男性与无睾丸功能减退症且无腹型肥胖症的男性后,我们发现死亡风险增加了 3.30 倍(HR = 3.30,95%CI = 1.21-8.71)。
同时患有睾丸功能减退症和腹型肥胖症的男性死亡风险更高。需要进一步研究睾丸功能减退症和腹型肥胖症共存的影响,采用更大规模和更长随访时间的研究。